Given the persistence of CD26+ LCSs in a subset of CML patients in stable and prolonged TFR, the question arises regarding the interaction of CML LSCs and the immune system. The gene discussed is DPP4; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.